ArticleFuture oncology (London, England)2024

Practice efficiency and total cost of care with bispecifics and CAR-T in relapsed/refractory diffuse large B-cell lymphoma: an institutional perspective.

Matthew Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.